Mannatech Successfully Enforces Its Ambrotose Patent Against a Nutritional Supplements Firm Based in the United Kingdom: Financial News - Yahoo! Finance:


COPPELL, Texas, April 6 /PRNewswire-FirstCall/ -- Global health and wellness leader Mannatech, Incorporated (Nasdaq: MTEX - News), has successfully enforced one of its product patents against Bion/Elphanta, a nutritional supplements firm based in the United Kingdom.

In an order filed with the High Court of Justice patents court in London, Bion agreed to stop breaching Mannatech's U.K. patent on technology related to Ambrotose complex, a unique glyconutritional formulation Mannatech introduced in 1996. Bion also agreed to stop the manufacture, sales and importation of all dietary supplements related to glyconutrition "in any form and by any means."

Mannatech filed the patent-infringement lawsuit in the U.K. against Bion and its principal in February 2005.

"Mannatech will defend its intellectual property and vigorously pursue infringements," said Bettina Simon, senior vice president and general counsel of Mannatech.